OraSure Technologies Inc - Company Profile
Powered by 
All the data and insights you need on OraSure Technologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date OraSure Technologies Inc Strategy Report
- Understand OraSure Technologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
OraSure Technologies Inc (OraSure) develops, manufactures, and distributes oral fluid diagnostic, collection devices and other diagnostic products for detection and diagnosis of critical medical conditions. Its product portfolio encompasses around infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific region. OraSure is headquartered in Bethlehem, Pennsylvania, the US.
Headquarters
United States of America
Address
220 E First St, Bethlehem, Pennsylvania, 18015
Website
www.orasure.com
Telephone
1 503 6416115
No of Employees
638
Industry
Medical Equipment
Ticker Symbol & Exchange
OSUR (NASD)
Revenue (2022)
$405.5M
4.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
413.2%
(2022 vs 2021)
Market Cap*
$407.0M
Net Profit Margin (2022)
XYZ
399.3%
(2022 vs 2021)
* As of and is in US$
OraSure Technologies Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Infectious Disease: | - |
| Rapid HIV-1/2 Antibody Test | OraSure |
| In-Home HIV Test | Intercept |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Others | In January, the company secured strategic distribution rights and invested in Sapphiros. |
| 2022 | Contracts/Agreements | In September, Diversigen entered into an agreement with Mars Petcare to assess pet health. |
| 2021 | Contracts/Agreements | In October, the company secured a US$109 million contract from the Air Force Life Cycle Management Center, Hanscom Air Force Base, Massachusetts for the increased domestic manufacturing capability of rapid antigen self-tests for home care testing. |
Competitor Comparison
| Key Parameters | OraSure Technologies Inc | Zoetis Inc | Trinity Biotech Plc | Psychemedics Corp | MedMira Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | Canada |
| City | Bethlehem | Parsippany | Bray | Acton | Halifax |
| State/Province | Pennsylvania | New Jersey | - | Massachusetts | Nova Scotia |
| No. of Employees | 638 | 14,100 | 398 | 116 | 65 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Carrie Eglinton Manner | President; Chief Executive Officer; Director | Executive Board | 2022 | 50 |
| Mara G. Aspinall | Chair | Executive Board | 2017 | 61 |
| Kenneth J. McGrath | Chief Financial Officer | Senior Management | 2022 | 52 |
| Michele Anthony | Senior Vice President; Controller; Chief Accounting Officer | Senior Management | 2022 | - |
| Kathleen G. Weber | Chief Product Officer | Senior Management | 2022 | 57 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer